rs61745578
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014704.4(CEP104):c.552A>T(p.Glu184Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,614,026 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E184Q) has been classified as Likely benign.
Frequency
Consequence
NM_014704.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP104 | NM_014704.4 | c.552A>T | p.Glu184Asp | missense_variant | 6/22 | ENST00000378230.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP104 | ENST00000378230.8 | c.552A>T | p.Glu184Asp | missense_variant | 6/22 | 5 | NM_014704.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00596 AC: 907AN: 152142Hom.: 10 Cov.: 32
GnomAD3 exomes AF: 0.00155 AC: 389AN: 251472Hom.: 1 AF XY: 0.00118 AC XY: 161AN XY: 135916
GnomAD4 exome AF: 0.000604 AC: 883AN: 1461766Hom.: 6 Cov.: 33 AF XY: 0.000542 AC XY: 394AN XY: 727190
GnomAD4 genome AF: 0.00597 AC: 909AN: 152260Hom.: 10 Cov.: 32 AF XY: 0.00622 AC XY: 463AN XY: 74458
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 05, 2021 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Joubert syndrome 25 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
CEP104-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 05, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at